Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingzhu Granules in Acute Gouty Arthritis
NCT06068478Phase 3Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Nov 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Qingshu Granules in gouty arthritis, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Nov 2023; status: completed.
02
Drugs
Qingshu Granules
03
Conditions
gouty arthritis
Beyond the preview
Go deeper on NCT06068478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06068478.